Assessing the evidence that antibiotic growth promoters influence human infections

Journal of Hospital Infection

Volumn 43, Issue 3, 1999, Pages 173-178

  Phillips, L ^a  

^a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AVOPARCIN; DALFOPRISTIN PLUS QUINUPRISTIN; GLYCOPEPTIDE; GROWTH PROMOTOR; PRISTINAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOGRAMIN DERIVATIVE; TEICOPLANIN; TYLOSIN; VANCOMYCIN; VETERINARY DRUG; VIRGINIAMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CAMPYLOBACTER; ENTEROCOCCUS FAECIUM; FOOD CONTAMINATION; HEALTH HAZARD; HUMAN; INFECTION RISK; NONHUMAN; REVIEW; SALMONELLA; STAPHYLOCOCCUS; ZOONOSIS;

EID: 0344146481     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhin.1999.0653     Document Type: Review

References (39)

1. FEDESA/ FEFANA Press release. 8 September 1998.
2. Piddock L. J. Does the use of antimicrobial agents in veterinary medicine and animal husbandry select antibiotic-resistant bacteria that infect man and compromise antimicrobial chemotherapy? J Antimicrob Chemother. 38:1996;1-3.
3. Gaunt P. N., Piddock L. Ciprofloxacin resistant Campylobacter spp in humans: an epidemiological and laboratory study. J Antimicrob Chemother. 37:1998;747-757.
4. DANMAP 97. Consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria ftom food, animals and humans in Denmark. Dansk Zoonosenter, Statens Veterinaere Serumlaboratorium, Bulowsvej 27, 1790 Copenhagen V, Demnark, 1998.
5. Welton L. A., Thal A., Perri M. B., Donabedian S., McMahon J., Chow J. W., Zervos M. J. Antimicrobial resistance in enterococci isolated from turkey flocks fed virginiamycin. Antimicrob Ag Chemother. 42:1998;705-708.
6. Murray B. E. vancomycin-resistant enterococci. Am J Med. 102:1997;284-293.
7. Schouten M. A., Hoogkamp-Korstanje J. A. A., Kraak W. A. G., Bartels C. J. M., Roelofs-Willemse HJM Voss A. Vancomycin-resistant enterococci (VRE) prevalence in Europe. Abstracts, 9th European Congress of Chemotherapy and Infectious Diseases, 1999. Clin Microbiol Infect. 5 suppl 3:1999;136.
8. WHO Division of Emerging and other Communicable Diseases, Surveillance and Control.The medical impact of the use of antimicrobials in food animals 13-17 October 1997, Berlin WMO/EMC/ZOO/97.4.
9. Ministry of Health and ministry of Food, Agriculture and Fisheries, Copenhagen, 9-10 September. 1998.
10. 28 May. 1999.
11. Report of the Scientific Committee for Animal Nutrition (SCAN) on the possible risk for humans on the use of avoparcin as feed additive, 21 May 1996, VI/6474/96-rev 1.
12. Opinion of the Scientific Committee for Animal Nutrition (SCAN) on the immediate and longer-term risk to the value of streptogramins in human medicine posed by the use of virginiamycin as an animal growth promoter, 10 July 1998.
13. Simonsen G. S., Borgen K., Schaller G., Olsvik O., Wasteson Y., Kruse H., Sundsfjord A. Extensive persistence of vancomycin-resistant enterococci on Norwegian poultry farms 3 years after the avoparcin ban. Abstracts, 9th European Congress of Clinical Microbiology and Infectious Diseases, 1999. Clin Microbiol Infect. 5: suppl 3:1999;O80.
14. Order of the President of the Court of First Instance, Luxembourg 30 June 1999. Reg No 127952.
15. Woodford N., Palepou M. F., Johnson A. P., Chadwick P. R., Bates J. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. Lancet. 350:1997;738.
16. Chadwick P. R., Woodford N., Kaczmarski E. B., Gray S., Barrell R. A., Oppenheim B. A. Glycopeptide-resistant enterococci isolated from uncooked meat. J Antimicrob Chemother. 38:1996;908-909.
17. Klein G., Pack A., Reuter G. Antibiotic resistance patterns of enterococci and occurrence of vancomycin-resistant enterococci in raw minced beef and pork in Germany. Appl Env Microbiol. 64:1998;1825-1830.
18. Bates J., Jordens J. Z., Griffiths D. T. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J Antimicrob Chemother. 34:1994;507-514.
19. Delmee M., Kersbergen J., Janssens M., Tollenaere J., Avesani V. Glycopeptide- resistant enterococci (GRE) in hospital food. Abstracts, 9th International Congress of Clinical Microbiology and Infectious Diseases, 1999. Clin Microbiol Infect. 5 suppl 3:1999;144.
20. Wemer G., Klare I., Witte W. Arrangement of the vanA gene cluster in enterococci of different ecological origin. FEMS Microbiol Lett. 155:1997;55-61.
21. Woodford N., Adebiyi A. A., Palepou M. I., Cookson B. D. Diversity of vanA glycopeptide resistance elements in enterococci frtom human and non-human sources. Antimicrob Ag Chemother. 42:1998;502-508.
22. Kirk M., Beighton D., Chen H. Y., Hill R., Casewell M. W. Phenotypic differentiation of human and poultry vancomycin-resistant Enterococcus faecium. 37th ICAAC, Toronto, 1997;Abstract C 135.
23. van den Bogaard A. E., Jensen L. B., Stobberingh E. E. Vancomycin-resistant enterococci in turkeys and farmers. New Engl J Med. 337:1997;1558-1559.
24. Goossens H., Descheemaeker P., Chapelle S., Leven M., Vandamme P., Devriese L. A. Comparison of human and animal Van A Enterococcus faecium in Belgium. Abstracts 9th ECCMID1999. Clin Micro Infect. 5 suppi 3:1999;141.
25. Berchieri A. Intestinal colonization of a human subject by vancomycin-resistant Enterococcus faecium. Clin Micro Infect. 5:1999;97-100.
26. Goossens H. Vancomycin-resistant Enterococcus faecium derived from animals colonising the human gut: the missing evidence? Clin Micro Infect. 5:1999;64-66.
27. Jones R. N., Ballow C. H., Biedenbach D. J., Deinhardt J. A., Shentag J. A. Antimicrobial activity of quinupristin/dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada. Diagn Microbiol Infect Dis. 30:1998;437-451.
28. Gordts B., van Landuyt H., Ieven M., Vandamme P., Goossens H. Vancomycin- resistant enterococci colonizing the intestinal tracts of hospitalized patients. J Clin Microbiol. 33:1995;2842-2846.
29. McCarthy L., Rao G. G., Lorek A. Outbreak of glycopeptide-resistant Enterococcus faecium in a neonatal unit. Clin Microbiol Infect. 5:1999;103-104.
30. Moellering R. C., Linden P. K., Reinhardt J. The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistantEnterococcus faecium. J Antimicrob Chemother. 44:1999;251-261.
31. Nichols R. L., Graham D. R., Barriere S. L. Treatment of hospitalized patients with complicated Gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. J Antimicrob Chemother. 44:1999;262-273.
32. Jensen L. B., Hammerdal A. M., Aarestrup F. M., van den Bogaard A. E., Stobberingh E. E. Occurrence of satA and vgb genes in streptogramin-resistant Enterococcus faecium isolates of animal and human origins in the Netherlands. Antimicr Ag Chemother. 42:1998;3330-3331.
33. Biedenbach D. J., Ballow C., Schentag J. J., Jones R. N. Quinupristin/dalfopristin antimicrobial activity and spectrum in North America: report from 1998 isolates in the global SMART survey. Abstracts 21st ICC Birmingham, 1999. J Antimicrob Chemother. 44:1999;168.
34. Gales A. C., Sader H. S., Jones R. N., Ballow C. H. Quinupristin/dalfopristin activity against Latin American Gram-positive cocci: results from the global SMART surveillance study. Abstracts 21st ICC Birmingham, 1999. J Antimicrob Chemother. 44:1999;205.
35. Fluit A., Jones R. N., Ballow C., Adelman M., Shentag J. J. Results from the European component of the global SMART program: activity of quinupristin/dalfopristin tested against Gram-positive cocci. Abstracts 21st ICC Birmingham, 1999. J Antimicrob Chemother. 44:1999;172.
36. Turnidge J., Bell J. Surveillance of resistance to Synercid (quinupristin/dalfopristin) in the Western Pacific. Abstracts 21st ICC Birmingham, 1999. J Antimicrob Chemother. 44:1999;197.
37. Leclercq, R. Thabaut, A. Etienne, J. et al., Actualisation de l'activité in vitro de quinupristin/dalfopristin sur les souches bactéiennes à l'hôpital en France. 18ème Réunion Interdisciplinaire de Chimothérapie anti-infectieuse, 1998. Resumé 80/P1.
38. Department of Health (UK). 1998.
39. Phillips I. Resistance from animals to man: assessing the evidence. Proceedings 4th International Conference of the Hospital Infection Society, Edinburgh, 1998. J Hosp Infect. 40 suppIA:1998;H8F.